EU Tamper-Evident Packaging Requirement To Cost Generics Firms $700M
This article was originally published in The Pink Sheet Daily
Executive Summary
Generics manufacturers are pressing for the removal of tamper-evident packaging requirements in the EU’s Falsified Medicines Directive, saying it will cost them almost $700 million.